DA-9601 for erosive gastritis: Results of a double-blind placebo-controlled phase III clinical trial

World Journal of Gastroenterology

Volumn 10, Issue 16, 2004, Pages 2379-2382

  Seol, Sang Yong ^a   Kim, Myung Hwan ^b   Ryu, Jong Sun ^c   Choi, Myung Gyu ^d   Shin, Dong Wook ^e   Ahn, Byoung Ok ^e  

^a Inje University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

^e Dong A Pharmaceutical Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARTEMISIA ASIATICA EXTRACT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CETRAXATE; DA 9601; PLACEBO; PLANT EXTRACT; STILLEN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EROSIVE GASTRITIS; FACE EDEMA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEADACHE; HEARTBURN; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; PHASE 3 CLINICAL TRIAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME;

EID: 4344673994     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i16.2379     Document Type: Article

References (24)

1. Talley NJ. Dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther 2002; 16(Suppl 4): 95-104
2. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol 2001; 32: 286-293
3. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45: II37-II42
4. Kurata JH, Haile BM. Epidemiology of peptic ulcer disease. Clin Gastroenterol 1984; 13: 289-307
5. Blecker U, Gold BD. Gastritis and peptic ulcer disease in childhood. Eur J Pediatr 1999; 158: 541-546
6. Taylor IL. Gastrointestinal hormones in the pathogenesis of peptic ulcer disease. Clin Gastroenterol 1984; 13: 355-382
7. Defize J, Meuwissen SG. Pepsinogens: an update of biochemical, physiological, and clinical aspects. J Pediatr Gastroenterol Nutr 1987; 6: 493-508
8. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
9. Whitehead R. The classification of chronic gastritis: current status. J Clin Gastroenterol 1995; 21(Suppl 1): S131-S134
10. Chen MY, Ott DJ, Clark HP, Gelfand DW. Gastritis: classification, pathology, and radiology. South Med J 2001; 94: 184-189
11. Yoshikawa T, Naito Y. The role of neutrophils and inflammation in gastric mucosal injury. Free Rad Res 2000; 33: 785-794
12. Kashiwagi H. Ulcers and gastritis. Endoscopy 2003; 35: 9-14
13. Talley NJ. Update on the role of drug therapy in non-ulcer dyspepsia. Rev Gastroenterol Disord 2003; 3: 25-30
14. Oh TY, Ryu BK, Yang JI, Kim WB, Park JB, Oh TY, Lee SD, Lee EB. Studies on antiulcer effects of DA-9601, an Artemisia herba extract against experimental gastric ulcers and its mechanism. J Appl Pharmacol 1996; 4: 111-121
15. Lee EB, Kim WB, Ryu BK, Ahn BO, Oh TY, Kim SH. Studies on protective effect of DA-9601, an Artemisiae Herba extract, against ethanol-induced gastric mucosal damage and its mechanism. J Appl Pharmacol 1997; 5: 202-210
16. Oh TY, Ryu BK, Ko JI, Ahn BO, Kim SH, Kim WB, Lee EB, Jin JH, Hahm KB. Protective effect of DA-9601, an extract of Artemisiae Herba, against naproxen-induced gastric damage in arthritic rats. Arch Pharm Res 1997; 20: 414-419
17. 4 in the human neutrophils and gastric mucosal cells. Korean J Physiol Pharmacol 1997; 1: 573-580
18. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Cho SW, Lee KM, Hahm KB. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 2001; 49: 364-371
19. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Cho W, Hahm KB. Oxidative damage are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Rad Biol Med 2001; 30: 905-915
20. Suzuki Y, Hayashi M, Ito M, Yamagami I. Anti-ulcer effects of 4′-(2-carboxyetyl) phenyl trans-4-aminomethyl cyclohexanecar boxylate hydrochloride (cetraxate) on various experimental gastric ulcers in rats. Jpn J Pharmacol 1976; 26: 471-480
21. Tachi K, Goto H, Hayakawa T, Sugiyama S. Prevention of water immersion stress-induced gastric lesions through the enhancement of nitric oxide synthase activity in rats. Aliment Pharmacol Ther 1996; 10: 97-103
22. Kim OJ, Kang KK, Kim DH, Baik NG, Ahn BO, Kim WB, Yang I. Four-week oral toxicity study of DA-9601, an antiulcer agent of Artemisia spp. Extract, in rats. J Appl Pharmacol 1996; 4: 354-363
23. 4-induced liver damage in rats. Arch Pharm Res 1998; 21: 508-513
24. Cheong JY, Oh TY, Lee KM, Kim DH, Ahn BO, Kim WB, Kim YB, Yoo BM, Hahm KB, Kim JH, Cho SW. Suppressive effects of antioxidant DA-9601 on hepatic fibrosis in rats. Korean J Hepatol 2002; 8: 436-447